Hemant Bhutani

1.2k total citations · 1 hit paper
24 papers, 981 citations indexed

About

Hemant Bhutani is a scholar working on Analytical Chemistry, Spectroscopy and Pharmacology. According to data from OpenAlex, Hemant Bhutani has authored 24 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Analytical Chemistry, 8 papers in Spectroscopy and 6 papers in Pharmacology. Recurrent topics in Hemant Bhutani's work include Analytical Chemistry and Chromatography (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Hemant Bhutani is often cited by papers focused on Analytical Chemistry and Chromatography (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Hemant Bhutani collaborates with scholars based in India, United States and France. Hemant Bhutani's co-authors include Raj Kumar, Saranjit Singh, Atish T. Paul, K Prabhakar, Priyadeep Bhutani, Gaurav Joshi, K.C. Jindal, T. Thanga Mariappan, Asit K. Chakraborti and Vijay Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

Hemant Bhutani

24 papers receiving 952 citations

Hit Papers

U.S. FDA Approved Drugs f... 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hemant Bhutani India 12 452 187 160 145 136 24 981
K. S. K. MURTHY Canada 18 483 1.1× 158 0.8× 143 0.9× 195 1.3× 112 0.8× 38 814
Laura L. Tomasevich United States 5 323 0.7× 126 0.7× 212 1.3× 174 1.2× 59 0.4× 5 673
Wojciech Bocian Poland 19 281 0.6× 340 1.8× 203 1.3× 95 0.7× 54 0.4× 72 836
Hongqin Yang China 25 270 0.6× 624 3.3× 116 0.7× 155 1.1× 127 0.9× 52 1.3k
Gregory W. Sluggett United States 19 603 1.3× 99 0.5× 84 0.5× 179 1.2× 111 0.8× 35 1.0k
K. B. Chandrasekhar India 17 306 0.7× 162 0.9× 206 1.3× 132 0.9× 111 0.8× 82 957
Milan Remko Slovakia 17 377 0.8× 229 1.2× 135 0.8× 71 0.5× 35 0.3× 39 786
Beata Liberek Poland 15 379 0.8× 313 1.7× 96 0.6× 154 1.1× 38 0.3× 71 833
Fan Chen China 24 885 2.0× 221 1.2× 55 0.3× 126 0.9× 220 1.6× 74 1.7k
Л. В. Спирихин Russia 15 793 1.8× 594 3.2× 87 0.5× 97 0.7× 59 0.4× 315 1.4k

Countries citing papers authored by Hemant Bhutani

Since Specialization
Citations

This map shows the geographic impact of Hemant Bhutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant Bhutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant Bhutani more than expected).

Fields of papers citing papers by Hemant Bhutani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemant Bhutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant Bhutani. The network helps show where Hemant Bhutani may publish in the future.

Co-authorship network of co-authors of Hemant Bhutani

This figure shows the co-authorship network connecting the top 25 collaborators of Hemant Bhutani. A scholar is included among the top collaborators of Hemant Bhutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemant Bhutani. Hemant Bhutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurmi, Moolchand, et al.. (2023). Actual Process Impurity or an Analytical Artifact? A Case Study Involving Conversion of Amide to Nitrile to Uncover the Truth and Mitigate. Organic Process Research & Development. 27(12). 2365–2373. 1 indexed citations
2.
Bhutani, Hemant, et al.. (2022). Mental Foramen Morphometrics on Cone-Beam Computed Tomography Determines Sexual Dimorphism. SHILAP Revista de lepidopterología. 13(1). 36–41. 1 indexed citations
3.
Bhutani, Priyadeep, Gaurav Joshi, K Prabhakar, et al.. (2021). U.S. FDA Approved Drugs from 2015–June 2020: A Perspective. Journal of Medicinal Chemistry. 64(5). 2339–2381. 566 indexed citations breakdown →
4.
Kurmi, Moolchand, et al.. (2021). Development of HPLC-CAD stability indicating assay method for polyethylene glycol-conjugated phospholipid (DMPE-PEG 2000) and identification of its degradation products. Journal of Pharmaceutical and Biomedical Analysis. 198. 113967–113967. 7 indexed citations
5.
Pan, Duohai, Ravi P. Shah, Balvinder S. Vig, et al.. (2020). Cross-linking of poly (vinyl alcohol) films under acidic and thermal stress. European Journal of Pharmaceutical Sciences. 152. 105429–105429. 12 indexed citations
7.
Kurmi, Moolchand, et al.. (2020). Identification of extractables by liquid chromatography-high resolution mass spectrometry: A case study to understand the extraction profile of different disposable syringes. Journal of Pharmaceutical and Biomedical Analysis. 191. 113602–113602. 5 indexed citations
8.
Jayaraman, K. S., et al.. (2020). A methodology employing retention modeling for achieving control space in liquid chromatography method development using quality by design approach. Journal of Chromatography A. 1635. 461658–461658. 6 indexed citations
9.
Sundaram, Meenakshi, et al.. (2020). Quantification of solid-state impurity with powder X-ray diffraction using laboratory source. Powder Diffraction. 35(4). 226–232. 8 indexed citations
10.
Dikundwar, Amol G., et al.. (2019). Solid State Behavior of Impurities during “In-Process” Phase Purity Analysis of an API. Organic Process Research & Development. 23(2). 269–273. 2 indexed citations
11.
Prasad, Bhagwat, Vijay Kumar, Hemant Bhutani, & Saranjit Singh. (2008). Screening of bulk drug samples and anti-tuberculosis products for the presence of therapeutically less active diasteriomeric (R,S) form of ethambutol dihydrochloride.. PubMed. 55(4). 192–8. 2 indexed citations
12.
Singh, Saranjit, Hemant Bhutani, & T. Thanga Mariappan. (2006). QUALITY PROBLEMS OF ANTI-TUBERCULOSIS FIXED-DOSE COMBINATIONS (FDCS): A WAY FORWARD. Indian Journal of Tuberculosis. 53(4). 11 indexed citations
13.
Kumar, Vijay, Hemant Bhutani, & Saranjit Singh. (2006). ICH guidance in practice: Validated stability-indicating HPLC method for simultaneous determination of ampicillin and cloxacillin in combination drug products. Journal of Pharmaceutical and Biomedical Analysis. 43(2). 769–773. 42 indexed citations
14.
Bhutani, Hemant, Saranjit Singh, Kamlesh K. Bhutani, et al.. (2006). LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. Journal of Pharmaceutical and Biomedical Analysis. 43(4). 1213–1220. 99 indexed citations
15.
Prasad, Bhagwat, Hemant Bhutani, & Saranjit Singh. (2006). Study of the interaction between rifapentine and isoniazid under acid conditions. Journal of Pharmaceutical and Biomedical Analysis. 41(4). 1438–1441. 16 indexed citations
16.
Mariappan, T. Thanga, et al.. (2005). Behavior of Moisture Gain and Equilibrium Moisture Contents (EMC) of Various Drug Substances and Correlation with Compendial Information on Hygroscopicity and Loss on Drying. Pharmaceutical Development and Technology. 10(4). 489–497. 18 indexed citations
17.
Bhutani, Hemant, Saranjit Singh, K.C. Jindal, & Asit K. Chakraborti. (2005). Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs. Journal of Pharmaceutical and Biomedical Analysis. 39(5). 892–899. 52 indexed citations
18.
Bhutani, Hemant, Saranjit Singh, & K.C. Jindal. (2005). Drug-Drug Interaction Studies on First-Line Anti-tuberculosis Drugs. Pharmaceutical Development and Technology. 10(4). 517–524. 28 indexed citations
19.
Bhutani, Hemant, T. Thanga Mariappan, & Saranjit Singh. (2004). An Explanation for the Physical Instability of a Marketed Fixed Dose Combination (FDC) Formulation Containing Isoniazid and Ethambutol and Proposed Solutions. Drug Development and Industrial Pharmacy. 30(6). 667–672. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026